🚨 TOXIC MUSHROOM EMERGENCY β€” South Africa Poison Helpline: 0861 555 777  |  Morocco CAPM: 0801 000 180  |  Kenya Emergency: 999

About This Guide

This guide covers four African bioregions: Mediterranean North Africa and South African temperate fynbos (amatoxin β€” Death Cap); East and Southern African miombo wooded savannas and anthropogenic lawns (Chlorophyllum molybdites GI toxidrome); West African industrial corridors with heavy metal co-exposure risk; and Central African equatorial forests (native tropical Amanita species with variable amatoxin content). Species data are confirmed from peer-reviewed literature and herbarium voucher sources.

Data-only reference β€” no photographs. Species identification for clinical management must be confirmed by a toxicologist, mycologist, or poison control specialist, not from this text alone.

☠ Region 1 β€” Mediterranean North Africa and South African Temperate Fynbos
Tier 1 β€” Lethal | Amatoxin Syndrome
Death Cap Tier 1 β€” Lethal
Amanita phalloides
Death Cap (English)  Β·  Chapeau de la mort (French)  Β·  Groen knolamaniet (Afrikaans)
Distribution
Morocco, Algeria, Tunisia; Western Cape, Eastern Cape, Mpumalanga (South Africa)
Habitat
Exotic mycorrhizal β€” strictly associated with mature Quercus, Pinus, or Populus trees
Fruiting Season
North Africa: Oct–Jan. South Africa: Apr–Jul.
Morphology
Cap 5–15 cm, pale olive-green to yellowish-green or pure white. Crowded white free gills. Prominent white ring. Distinct sac-like volva at base.
Lookalike Confusion
Misidentified as edible white Agaricus field mushrooms or edible Volvariella species when the underground basal volva is missed during harvesting.
Voucher Sources
Compton Herbarium (NBG), Cape Town; National Herbarium of Morocco (RAB), Rabat
⚠ FALSE RECOVERY PHASE: After 24–48h of apparent improvement β€” including resolution of GI symptoms β€” hepatocyte destruction continues silently. Do NOT discharge. ICU admission and liver transplant evaluation must be initiated EARLY regardless of apparent clinical recovery.

Pathophysiology

Classic triphasic amatoxin syndrome. Amatoxins inhibit RNA polymerase II, halting cellular protein synthesis, causing progressive, irreversible hepatocellular and renal tubular necrosis.

Clinical Timeline

  • Phase 1 (6–24 hours): Delayed onset β€” severe cholera-like gastroenteritis (nausea, projectile vomiting, watery diarrhea, cramping)
  • Phase 2 (24–48 hours): False recovery window β€” latent phase. Symptoms appear to resolve. Transaminases rising silently. DO NOT DISCHARGE.
  • Phase 3 (48–96 hours): Fulminant hepatic necrosis, acute kidney injury, coagulopathy, hepatic encephalopathy, multi-organ failure

ICU Protocol β€” Adults

  • Aggressive IV fluid resuscitation targeting urine output 100–200 mL/hour to enhance amatoxin renal clearance
  • Multi-dose activated charcoal (MDAC) via NG tube: 1 g/kg every 4 hours β€” interrupts enterohepatic recirculation
  • Meixner test: Apply mushroom juice to newspaper; blue-black color change = amatoxins present. CRITICAL WARNING: A negative Meixner test does NOT exclude amatoxin poisoning β€” do not use a negative result to rule out Amanita phalloides ingestion.
  • Continuous IV Silibinin (Legalon SIL) 20–30 mg/kg/day β€” uninterrupted infusion. Do not hold for any reason.
  • OR high-dose Benzylpenicillin (Penicillin G) 300,000–1,000,000 units/kg/day if Silibinin unavailable
  • IV N-Acetylcysteine (NAC) β€” extended four-bag regimen:
    • Bag 1: 150 mg/kg over 60 min
    • Bag 2: 50 mg/kg over 4 hours
    • Bag 3: 100 mg/kg over 16 hours
    • Bag 4: Continue 150–300 mg/kg/day until clinical resolution
  • Monitor PT/INR, AST/ALT, total bilirubin, creatinine every 6 hours
  • King's College Criteria: Evaluate for liver transplantation eligibility early β€” do not wait for peak deterioration

Pediatric Dosing

  • Activated charcoal: 0.5–1 g/kg (max 50 g) every 4 hours via NG tube
  • Silibinin: 20 mg/kg/day IV continuous infusion
  • NAC: Same weight-based four-bag regimen as adults
  • Fluid resuscitation: 10–20 mL/kg boluses of normal saline, reassess every 30 minutes

Veterinary

Canine: Severe RNA polymerase II inhibition resulting in total liver failure. Mortality exceeds 85%. Emergency IV fluid support and referral to veterinary ICU.

Feline: Severe hepatocyte necrosis. Exposure frequently occurs via grooming spores or fungal debris from paws. Same hepatotoxic pathway.

⚠ Region 2 β€” East and Southern African Miombo Wooded Savannas and Anthropogenic Lawns
Tier 2 β€” Severe Morbidity | GI Toxidrome
False Parasol / Green-gilled Parasol Tier 2 β€” Severe Morbidity
Chlorophyllum molybdites
Green-gilled Parasol (English)  Β·  Groengif-parasol (Afrikaans)
Distribution
Zimbabwe, Zambia, Kenya, Tanzania, South Africa β€” frequently in fairy rings in suburban lawns
Habitat
Open grasslands, residential lawns, pastures, golf courses. Frequently in large visible fairy rings. Elevation 0–1600 m.
Fruiting Season
Rainy season cycles, typically spring through autumn
Morphology
Large sturdy cap 10–30 cm. Irregular brownish scales on white to buff backdrop. Gills transform from white to distinct dull olive-green at maturity, dropping green spores.
Lookalike Confusion
Misidentified as edible Macrolepiota (Parasol) or Agaricus species, which lack green gills and green spore prints at maturity.
Voucher Sources
National Herbarium of South Africa (PRE), Pretoria

Pathophysiology

Driven by the toxic metalloendopeptidase molybdophyllysin, which causes severe localized gastrointestinal cytotoxicity.

Clinical Timeline

  • Onset: 30 minutes to 2.5 hours post-ingestion
  • Symptoms: Immediate projectile vomiting, explosive watery green or bloody diarrhea, agonizing abdominal cramps, rapid hypovolemic shock

ICU Protocol

  • Aggressive fluid resuscitation with IV balanced crystalloids
  • IV antiemetics: Ondansetron 4–8 mg IV or Metoclopramide
  • Monitor serum electrolytes β€” critical attention to hypokalemia
  • DO NOT administer Loperamide or Diphenoxylate β€” contraindicated
  • Condition is self-limiting, typically resolves within 24–48 hours with supportive care

Veterinary

Canine: Leading cause of suburban yard mushroom poisonings in domestic dogs across Africa. Triggers hypovolemic shock and severe dehydration β€” fatal without prompt veterinary IV fluid therapy.

Feline: Severe gastrointestinal distress and rapid dehydration. Requires immediate veterinary triage.

⚠ Region 3 β€” West Africa: Nigerian and Ghanaian Industrial Corridors
Tier 2 β€” Severe Morbidity with Heavy Metal Co-Exposure Risk
False Parasol β€” West Africa Tier 2 + Heavy Metal Risk
Chlorophyllum molybdites (confirmed from peer-reviewed literature)
Distribution
Nigeria, Ghana β€” suburban lawns, open grasslands, peri-urban zones near industrial corridors
Standard GI Protocol
Same as Region 2 β€” molybdophyllysin-driven GI toxidrome, 30 min to 2.5 hours onset
🏭 CRITICAL CLINICAL NOTE β€” HEAVY METAL BIOACCUMULATION: Peer-reviewed literature documents significant bioaccumulation of heavy metals β€” lead (Pb), cadmium (Cd), and chromium (Cr) β€” in wild-harvested fungi from industrial corridors in Nigeria and Ghana. Wild mushroom ingestion in these areas carries a dual toxicological burden: the primary molybdophyllysin GI toxidrome may be compounded by heavy metal co-exposure.

Clinical Implications of Heavy Metal Co-Exposure

  • More severe and prolonged GI symptoms than typical Chlorophyllum molybdites cases
  • Risk of acute heavy metal toxicity: renal tubular injury (cadmium), neurotoxicity (lead), hepatotoxicity (chromium)
  • Order serum lead, cadmium, and chromium levels in West African cases alongside standard GI workup
  • Consider chelation consultation if heavy metal levels are elevated
☠ Region 4 β€” Central Africa: DRC and Congo Basin Equatorial Forests
Tier 1 β€” Presumed Lethal | Variable Amatoxin Content
Native Tropical Amanita Species Tier 1 β€” Presumed Lethal
Amanita loosii / Amanita masasiensis (confirmed from peer-reviewed literature)
Distribution
Democratic Republic of Congo, Republic of Congo β€” equatorial rainforest zones
Notes
Native tropical Amanita species distinct from European A. phalloides. Documented to contain variable amatoxins. Treat under full amatoxin protocol pending species confirmation.

Pathophysiology

Amatoxin mechanism β€” RNA polymerase II inhibition. Variable amatoxin concentration across specimens; treat all suspected cases as high-risk.

Diagnostic Flowchart β€” Onset Timing Differentiation

Symptom Onset Timing Algorithm

Onset UNDER 3 Hours

  • Suspect neurotoxic Amanita syndrome OR Chlorophyllum molybdites
  • Immediate GI decontamination, supportive care, monitor neurological status
  • If neurological symptoms (seizures, altered consciousness): rule out Amanita muscaria/pantherina group

Onset OVER 6 Hours

  • Suspect hepatotoxic amatoxin syndrome β€” Amanita loosii / Amanita masasiensis / Amanita phalloides
  • Initiate full amatoxin ICU protocol IMMEDIATELY β€” do NOT wait for laboratory confirmation
  • Begin Silibinin infusion, MDAC, NAC four-bag regimen
  • Serial liver and renal function monitoring every 6 hours

Pediatric Fluid Formulas

  • Fluid resuscitation: 10–20 mL/kg normal saline bolus, reassess every 30 minutes
  • Maintenance fluids: 4 mL/kg/hour for first 10 kg, 2 mL/kg/hour for next 10 kg, 1 mL/kg/hour thereafter
  • Activated charcoal: 0.5–1 g/kg every 4 hours via NG tube
  • Monitor glucose β€” hypoglycemia common in pediatric amatoxin cases; correct with D10W infusion

Edible vs Toxic Lookalike Reference

Edible SpeciesToxic LookalikeKey Differentiator
Termitomyces spp. (Termite mushroom)Chlorophyllum molybditesTermitomyces lacks green gills and green spore print; grows from termite mounds
Volvariella spp. (Straw mushroom)Amanita phalloides / Amanita loosiiVolvariella lacks a ring; Amanita has both ring AND volva

Nursing ICU Flowsheet β€” Amatoxin Protocol

FrequencyMonitoring / Intervention
HourlyUrine output (target 100–200 mL/hr), vital signs, GCS
Every 4 hoursActivated charcoal via NG tube, fluid balance assessment
Every 6 hoursPT/INR, AST/ALT, total bilirubin, creatinine, electrolytes
DailyAbdominal ultrasound (hepatomegaly, ascites), transplant eligibility reassessment
ContinuousIV Silibinin infusion β€” document any interruptions as clinical events

Bilingual Community Warning

πŸ‡¬πŸ‡§ English

Do not eat wild mushrooms from the forest or ground without expert identification. Some mushrooms that look safe can cause severe liver failure and death. If someone eats a wild mushroom and feels sick, call emergency services immediately β€” do not wait.

πŸ‡«πŸ‡· FranΓ§ais

Ne consommez pas de champignons sauvages de la forΓͺt ou du sol sans identification par un expert. Certains champignons d'apparence inoffensive peuvent provoquer une insuffisance hΓ©patique grave et la mort. Si quelqu'un mange un champignon sauvage et se sent mal, appelez immΓ©diatement les services d'urgence β€” n'attendez pas.

πŸ“ž Poison Control Contacts
πŸ‡ΏπŸ‡¦ South Africa

Poisons Information Helpline (routes to Tygerberg Hospital or Red Cross War Memorial Children's Hospital):
πŸ“ž 0861 555 777

Ambulance: πŸš‘ 10177   Mobile Emergency: 112

Referral: Tygerberg Hospital Poisons Information Centre (Western Cape); Chris Hani Baragwanath Academic Hospital (Gauteng)

Protocol: Delayed presentation >6 hours β€” immediate stabilization and fast-track to tertiary ICU with renal replacement capability

πŸ‡²πŸ‡¦ Morocco

Centre Anti Poison et de Pharmacovigilance du Maroc (CAPM):
πŸ“ž 0801 000 180

Ambulance: πŸš‘ 150

Referral: HΓ΄pital Militaire d'Instruction Mohammed V / CHU Ibn Sina, Rabat

Protocol: Delayed symptom window >6 hours β€” fast-track to nearest provincial tertiary ICU hub

πŸ‡°πŸ‡ͺ Kenya

Kenyatta National Hospital Emergency Hotline:
πŸ“ž +254 20 2726300

Emergency: πŸš‘ 999   112

Referral: Clinical Toxicology Unit, Kenyatta National Hospital, Nairobi

Protocol: Severe ingestions β€” stabilize with immediate fluid management, route directly to KNH Nairobi or nearest regional referral teaching hospital with ICU capability

πŸ”— Cross-Reference Flags

Species Covered in Multiple Regional Guides

πŸ“‹ Clinical Discharge Summary Template β€” ModΓ¨le de RΓ©sumΓ© de Sortie Clinique

Clinical Discharge Summary Template / Modèle de Résumé de Sortie Clinique

[1] Patient Administrative Registration / Enregistrement Administratif du Patient

Patient Name / Nom du Patient:

____________________________________________

National ID or Passport / NΒ° d'IdentitΓ© National ou Passeport:

____________________________________________

Date of Admission / Date d'Admission: ___/___/_____

Date of Discharge / Date de Sortie: ___/___/_____

Referring Clinic / Clinique d'Origine:

____________________________________________

[2] Clinical Diagnostic Summary / RΓ©sumΓ© Diagnostique Clinique

Primary Diagnosis / Diagnostic Principal:

____________________________________________

Secondary Complications / Complications Secondaires:

____________________________________________

Key Biomarker Trends / Tendances des Biomarqueurs ClΓ©s:

Baseline Values / Valeurs de Base:

____________________________________________

Peak Values / Valeurs Maximales:

____________________________________________

Discharge Values / Valeurs Γ  la Sortie:

____________________________________________

[3] Inpatient Therapeutic Summary / RΓ©sumΓ© ThΓ©rapeutique Hospitalier

Interventions Deployed / Interventions DΓ©ployΓ©es:

Critical Care Stabilization / Stabilisation en Soins Critiques
Pharmacological Management / Gestion Pharmacologique
Fluid Resuscitation / RΓ©animation Fluidique
Specialized Organ Support / Soutien Organique SpΓ©cialisΓ©
Diagnostic Imaging / Imagerie Diagnostique

[4] Mandated Outpatient Follow-Up / Suivi Ambulatoire Obligatoire

Initial Review / Premier Examen: Date ___/___/_____

Secondary Review / Deuxième Examen: Date ___/___/_____

Long-Term Follow-Up / Suivi Γ  Long Terme: Date ___/___/_____

Red Flag Return Criteria: Return to emergency center immediately if deterioration in physical or cognitive status, or any signs of acute organ distress. / Se prΓ©senter immΓ©diatement aux urgences en cas de dΓ©tΓ©rioration de l'Γ©tat physique ou cognitif, ou de tout signe de dΓ©tresse organique aiguΓ«.

[5] Regional Health Notification / Notification Sanitaire RΓ©gionale

This clinical record should be shared with relevant regional health authorities or specialized monitoring services as per local regulations. / Ce dossier clinique doit Γͺtre partagΓ© avec les autoritΓ©s sanitaires rΓ©gionales compΓ©tentes selon les rΓ©glementations locales.

Discharging Physician Name / Nom du MΓ©decin:

____________________________________________

Professional Registry Number / NumΓ©ro d'Ordre:

____________________________________________

Signature & Institutional Stamp / Signature et Cachet Institutionnel: ______________________ Date: ___/___/_____

πŸ“± QR Code β€” Share This Guide

Scan to open this guide on any device

https://www.sporeandscout.com/guides/toxic-mushroom-clinical-reference-africa

Share this URL with emergency department colleagues, poison control staff, EMS providers, and rural healthcare workers across Africa.

Copies full clinical reference content to clipboard for EMR notes, referrals, or handoff documentation.

Medical Disclaimer: This guide is a rapid-reference clinical resource for emergency physicians, toxicologists, EMS providers, poison control specialists, and trained healthcare workers. It does not replace direct consultation with a regional poison control center, a toxicologist, or a clinical specialist. Drug doses, treatment protocols, and laboratory thresholds should be verified against current institutional formularies and national treatment guidelines. Patient management decisions must be made by qualified clinicians on the basis of individual clinical assessment. Species identification based on text descriptions alone is insufficient for definitive clinical diagnosis β€” contact a mycologist or poison control specialist for confirmation.